| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-12 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |